AstraZeneca PLCAZNNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank41
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P41
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.33% |
| Q3 2025 | 1.81% |
| Q2 2025 | 5.81% |
| Q1 2025 | 2.13% |
| Q4 2024 | -0.85% |
| Q3 2024 | 0.56% |
| Q2 2024 | 2.00% |
| Q1 2024 | 1.16% |
| Q4 2023 | 5.24% |
| Q3 2023 | -0.47% |
| Q2 2023 | -0.15% |
| Q1 2023 | 0.21% |
| Q4 2022 | 2.44% |
| Q3 2022 | -2.48% |
| Q2 2022 | -3.68% |
| Q1 2022 | -4.83% |
| Q4 2021 | -1.73% |
| Q3 2021 | 45.60% |
| Q2 2021 | 13.42% |
| Q1 2021 | -2.70% |
| Q4 2020 | 4.08% |
| Q3 2020 | 6.98% |
| Q2 2020 | 4.75% |
| Q1 2020 | -6.79% |
| Q4 2019 | 4.19% |
| Q3 2019 | -4.82% |
| Q2 2019 | 1.37% |
| Q1 2019 | 0.67% |
| Q4 2018 | -1.29% |
| Q3 2018 | 0.16% |
| Q2 2018 | -3.06% |
| Q1 2018 | -0.12% |
| Q4 2017 | -1.91% |
| Q3 2017 | -0.82% |
| Q2 2017 | 6.82% |
| Q1 2017 | -2.51% |
| Q4 2016 | -1.10% |
| Q3 2016 | -1.86% |
| Q2 2016 | 0.15% |
| Q1 2016 | 6.98% |